Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience

There has been a substantial expansion in the possibilities of current therapy for rheumatic diseases (RD) primarily due to the use of genetically engineered biological agents (GEBA). Objective: to evaluate the short-term efficacy and safety of GEBA in patients with different RD. Subjects and method...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: N A Mukhin, P I Novikov, Sergey Valentinovich Moiseev, T M Ignatova, L V Kozlovskaya, E N Semenkova, V V Fomin, S V Gulyaev, T N Krasnova, L A Strizhakov, T N Yanushkevich, V V Panasyuk, N V Nikiforova, S V Roshchupkina, Yu D Sorokin, A D Meshkov, L V Dubrovskaya, E S Zhabina, S A Parfenova, E I Kuznetsova, I A Lopatina
Formato: Artigo
Idioma:Russo
Publicado em: IMA-PRESS LLC 2013-04-01
Colecção:Научно-практическая ревматология
Assuntos:
rheumatoid arthritis
systemic lupus erythematosus
systemic vasculitis
granulomatosis with polyangiitis (wegener)
biological agents
rituximab
Acesso em linha:https://rsp.mediar-press.net/rsp/article/view/778
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados